TAKEDA PHARM SP ADR (TAK)
$15.17
0.00 (0.00%)
TAK Stock Quote Delayed 30 Minutes
Analytics for Earnings Growth Make Shire (SHPG) a Sell
Currently, Shire plc (NASDAQ:SHPG) has a Sell using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. SHPG has maintained this ranking for 11 months.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$15.00
Market Cap
24.01B
PE Ratio
0.17
EPS
91.16
Volume (Avg. Vol.)
1.57M
Day's Range
$15.08 - $15.22
52-Week Range
$12.29 - $15.22
Dividend & Yield
$0.62 (4.08%)
TAK Stock Predictions, Articles, and TAKEDA PHARM SP ADR News
Sell Rating on Shire (SHPG) Shares Extended
Shire plc (NASDAQ:SHPG) is ranked as a Sell using Louis Navellier's investing system and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking SHPG has had from Portfolio Grader for 11 months.
Is Now the Time to Buy Into These 5 Biotech ETFs?
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out
SPDR S&P Biotech (ETF) (XBI): Get on Board the Biotech Train!
Biotech stocks have gained the wind, but the SPDR S&P Biotech (ETF) (XBI) hasn't yet caught up with the market. That's going to change soon.
Merrimack Pharmaceuticals Inc (MACK) Stock Soars on Ipsen Deal
Merrimack Pharmaceuticals Inc (MACK) stock was up on Monday following news that it will sell some of its drugs to Ipsen.
Ariad Pharmaceuticals, Inc. (ARIA) Stock Higher on Takeda Buyout News
Ariad Pharmaceuticals, Inc. (ARIA) shares are skyrocketing on the news that Japanese pharmaceutical company Takeda could buy out the company soon.
13 Biotechnology Stocks to Buy Now
This week, 13 Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
7 Biotechnology Stocks to Buy Now
The grades of 7 Biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Hottest Manufacturing Stocks Now – FGEN LXRX X ARIA
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Hottest Manufacturing Stocks Now – CEMP IONS CC WATT
The following stocks were moving the Manufacturing sector today.
23 Biotechnology Stocks to Sell Now
This week, the ratings of 23 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Biggest Movers in Manufacturing Stocks Now – MTL BEAV RXN BCRX
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
30 Biotechnology Stocks to Sell Now
The ratings of 30 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Biggest Movers in Manufacturing Stocks Now – CERC KMG ASMB SKY
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
24 Biotechnology Stocks to Buy Now
24 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
25 Biotechnology Stocks to Buy Now
25 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
3 Big Stock Charts: United States Oil Fund LP ETF (USO), Chesapeake Energy Corporation (CHK) and Ariad Pharmaceuticals, Inc. (ARIA)
Shares of USO and CHK are ready to climb the Wall of Worry, but Ariad Pharmaceuticals, Inc. (ARIA) is ready to pullback more than 10%.
3 Stocks to Watch Wednesday: KB Home (KBH), Ariad Pharmaceuticals, Inc. and Microsoft Corporation (MSFT)
Ariad Pharmaceuticals (ARIA) is moving on buyout speculation, KB Home (KBH) delivers a mixed report and Microsoft (MSFT) doles out more cash to shareholders.
4 Biotechnology Stocks to Buy Now
The grades of 4 Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
3 Big Stock Charts: Nvidia Corporation (NVDA), Micron Technology, Inc. (MU) and Ariad Pharmaceuticals, Inc. (ARIA)
Ariad Pharmaceuticals (ARIA) is ready to break higher, while Nvidia (NVDA) and Micron Technology (MU) are buy-the-dip candidates.
